Nathalie Cartier will give an oral presentation during the Opening session Tuesday 17 october, entitled:
â€śClinical gene therapy for neurodegenerative diseases: Past, present, and futureâ€ť
Nathalie Cartier will give another talk on Wednesday 18 october during the session 1b: Ocular and central nervous system gene and cell therapy, entitled :
â€śAAV-mediated CYP46A1 gene therapy for Huntingtonâ€™s diseaseâ€ť
Sandro Alves will give a short presentation on Wednesday 18 october during session 2a: Ocular and central nervous system gene and cell therapy, entitled :
â€śAAV-CYP46A1 is beneficial in Alzheimerâ€™s disease: From mice to non-human primatesâ€ť
These results will be also presented in poster P221.